Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression

Details for Australian Patent Application No. 2006331733 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Reitz, Allen B.; Smith-Swintosky, Virginia L.

Agent Shelston IP

Pub. Number AU-A-2006331733

PCT Pub. Number WO2007/075751

Priority 11/612,249 18.12.06 US; 60/751,730 19.12.05 US

Filing date 19 December 2006

Wipo publication date 5 July 2007

International Classifications

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/353 (2006.01)

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/075751 Priority application(s): WO2007/075751

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006331734-Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain

2006331731-Niacin receptor agonists, compositions containing such compounds and methods of treatment